PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
0.889
-0.006 (-0.62%)
At close: Jun 26, 2026, 4:00 PM EDT
0.901
+0.012 (1.40%)
After-hours: Jun 26, 2026, 7:30 PM EDT

PDS Biotechnology Statistics

Total Valuation

PDSB has a market cap or net worth of $49.59 million. The enterprise value is $43.79 million.

Market Cap 49.59M
Enterprise Value 43.79M

Important Dates

The next estimated earnings date is Wednesday, August 12, 2026, before market open.

Earnings Date Aug 12, 2026
Ex-Dividend Date n/a

Share Statistics

PDSB has 55.82 million shares outstanding. The number of shares has increased by 32.34% in one year.

Current Share Class 55.82M
Shares Outstanding 55.82M
Shares Change (YoY) +32.34%
Shares Change (QoQ) +7.57%
Owned by Insiders (%) 2.53%
Owned by Institutions (%) 9.52%
Float 54.40M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 12.74
P/TBV Ratio 12.74
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.26, with a Debt / Equity ratio of 4.07.

Current Ratio 2.26
Quick Ratio 2.13
Debt / Equity 4.07
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -5.34

Financial Efficiency

Return on equity (ROE) is -254.09% and return on invested capital (ROIC) is -59.27%.

Return on Equity (ROE) -254.09%
Return on Assets (ROA) -50.49%
Return on Invested Capital (ROIC) -59.27%
Return on Capital Employed (ROCE) -199.49%
Weighted Average Cost of Capital (WACC) 16.26%
Revenue Per Employee n/a
Profits Per Employee -$1.59M
Employee Count 21
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -41.16% in the last 52 weeks. The beta is 1.56, so PDSB's price volatility has been higher than the market average.

Beta (5Y) 1.56
52-Week Price Change -41.16%
50-Day Moving Average 1.09
200-Day Moving Average 0.92
Relative Strength Index (RSI) 41.17
Average Volume (20 Days) 821,237

Short Selling Information

The latest short interest is 1.76 million, so 3.15% of the outstanding shares have been sold short.

Short Interest 1.76M
Short Previous Month 1.85M
Short % of Shares Out 3.15%
Short % of Float 3.23%
Short Ratio (days to cover) 1.69

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -28.96M
Pretax Income -33.36M
Net Income -33.36M
EBITDA -28.90M
EBIT -28.96M
Earnings Per Share (EPS) -$0.67
Full Income Statement

Balance Sheet

The company has $21.66 million in cash and $15.86 million in debt, giving a net cash position of $5.80 million or $0.10 per share.

Cash & Cash Equivalents 21.66M
Total Debt 15.86M
Net Cash 5.80M
Net Cash Per Share $0.10
Equity (Book Value) 3.89M
Book Value Per Share 0.07
Working Capital 12.74M
Full Balance Sheet

Cash Flow

Operating Cash Flow -23.09M
Capital Expenditures n/a
Depreciation & Amortization 60,518
Net Borrowing -5.94M
Free Cash Flow -23.09M
FCF Per Share -$0.41
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

PDSB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -32.34%
Shareholder Yield -32.34%
Earnings Yield -67.26%
FCF Yield -46.56%

Analyst Forecast

The average price target for PDSB is $7.50, which is 744.12% higher than the current price. The consensus rating is "Strong Buy".

Price Target $7.50
Price Target Difference 744.12%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on March 18, 2019. It was a reverse split with a ratio of 1:20.

Last Split Date Mar 18, 2019
Split Type Reverse
Split Ratio 1:20

Scores

Altman Z-Score n/a
Piotroski F-Score 1